Aditxt
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aditxt and other ETFs, options, and stocks.About ADTX
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore.
CEOAmro Albanna
CEOAmro Albanna
Employees26
Employees26
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded2017
Founded2017
Employees26
Employees26
ADTX Key Statistics
Market cap3.79M
Market cap3.79M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume95.32K
Average volume95.32K
High today$1.84
High today$1.84
Low today$1.71
Low today$1.71
Open price$1.74
Open price$1.74
Volume32.05K
Volume32.05K
52 Week high$27,200.00
52 Week high$27,200.00
52 Week low$1.51
52 Week low$1.51
ADTX News
TipRanks 4d
Aditxt Ends Agreement with Appili TherapeuticsConfident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market...
TipRanks 4d
Appili Therapeutics Faces Termination of Agreement with AditxtConfident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market...
TipRanks 4d
Aditxt announces termination of arrangement agreement with Appili TherapeuticsAditxt (ADTX) announced that it has determined it is in the best interest of the company and its stockholders to terminate the previously announced arrangement...
People also own
Based on the portfolios of people who own ADTX. This list is generated using Robinhood data, and it’s not a recommendation.